NYSE:KVUE

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Kenvue, Inc. (KVUE) Investors with Substantial Losses to Contact its Attorneys, Deadline Approaching in Securities Class Action

Retrieved on: 
Monday, November 20, 2023
Risk, Phenylephrine, FDA, Hagens Berman, SAN, KVUE, Person, IPO

SAN FRANCISCO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Kenvue, Inc. (NYSE: KVUE) investors who invested in Kenvue shares pursuant or traceable to Kenvue’s May 2023 initial public offering and who suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Kenvue, Inc. (NYSE: KVUE) investors who invested in Kenvue shares pursuant or traceable to Kenvue’s May 2023 initial public offering and who suffered substantial losses to submit your losses now .
  • On or around Sept. 12, 2023, the FDA published a briefing document announcing that it was convening an advisory committee to discuss efficacy data available for orally administered phenylephrine as a nasal decongestant.
  • “We’re focused on investors’ losses and investigating whether Kenvue adequately disclosed commercial risks related to its products containing PE,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.

DEADLINE ALERT for GCT, DLO, AAP, and KVUE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, November 20, 2023
Suite, DLocal, Risk, Phenylephrine, Disclosure, Register, Law, Perception, Investment, Defendant, Security (finance)

LOS ANGELES, Nov. 20, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Nov. 20, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • The Law Offices of Frank R. Cruz, Los Angeles

DEADLINE ALERT for AAP, KVUE, CGRN, NKLA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, November 20, 2023
Telephone, Suite, Risk, Phenylephrine, Class, Law, Bank statement, Perception, Investment, Safety, Security (finance)

BENSALEM, Pa., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • BENSALEM, Pa., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected] .
  • Law Offices of Howard G. Smith

Thinking about trading options or stock in Kenvue, Advanced Micro Devices, Apple, Walmart, or Hut 8?

Retrieved on: 
Tuesday, December 19, 2023
Report, WMT, HUT, AMD, AAPL, KVUE, Retail

NEW YORK, Dec. 19, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for KVUE, AMD, AAPL, WMT, and HUT.

Key Points: 
  • NEW YORK, Dec. 19, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for KVUE, AMD, AAPL, WMT, and HUT.
  • Click a link below then choose between in-depth options trade idea report or a stock score report.
  • Options Report – Ideal trade ideas on up to seven different options trading strategies.
  • The report shows all vital aspects of each option trade idea for each stock.

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Kenvue Inc.(KVUE) Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Monday, November 20, 2023
KVUE, NYSE, Telephone, LLP, Risk, CASE, Phenylephrine, Prospectus, CLASS, Person, NEXT, Court, COST, IPO

NEW YORK, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Kenvue Inc. ("Kenvue" or the "Company") (NYSE: KVUE) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Kenvue Inc. ("Kenvue" or the "Company") (NYSE: KVUE) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Kenvue investors who were adversely affected by alleged securities fraud.
  • Follow the link below to get more information and be contacted by a member of our team:
    KVUE investors may also contact Joseph E. Levi, Esq.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

KENVUE ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Kenvue To Contact Him Directly To Discuss Their Options

Retrieved on: 
Sunday, November 19, 2023
Defendant, KVUE, NYSE, Johnson & Johnson, Advertising, LLP, Registration statement, Complaint, Risk, Woman, Phenylephrine, FDA, Prospectus, Court, Security (finance), Pharmaceutical industry, IPO

NEW YORK, Nov. 19, 2023 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Kenvue Inc. (“Kenvue” or the “Company”) (NYSE: KVUE) and reminds investors of the December 8, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Key Points: 
  • Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
  • In May 2023, Kenvue conducted an IPO, offering approximately 171,812,560 shares of Kenvue common stock to the investing public at $22.00 per share.
  • Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
  • Faruqi & Faruqi, LLP also encourages anyone with information regarding Kenvue’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

ROSEN, A TOP RANKED LAW FIRM, Encourages Kenvue Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KVUE

Retrieved on: 
Saturday, November 18, 2023
Titan, KVUE, NYSE, Advertising, Phenylephrine, Registration statement, Prospectus, Register, I-Space (Chinese company), Court, Insurance, Tobacco, IPO

WHAT TO DO NEXT: To join the Kenvue class action, go to https://rosenlegal.com/submit-form/?case_id=19241 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Kenvue class action, go to https://rosenlegal.com/submit-form/?case_id=19241 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Class Action Lawsuit Filed Against Kenvue Inc. (KVUE) on Behalf of Investors – Nationally Ranked Investors’ Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

Retrieved on: 
Friday, November 17, 2023
Risk, KVUE, ISS, Fraud, Loss, NYSE, Phenylephrine, Register, Registration statement, IPO

ATLANTA, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against Kenvue Inc. (“Kenvue” or the “Company”) (NYSE: KVUE).

Key Points: 
  • ATLANTA, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against Kenvue Inc. (“Kenvue” or the “Company”) (NYSE: KVUE).
  • at [email protected] , by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/kenvue/ to learn more.
  • Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021 and 2022, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation.
  • Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.

Class-Action Accuses Kenvue, Inc. (KVUE) of Not Disclosing Known Commercial Risks to Cold Medicine Drugs, says HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS

Retrieved on: 
Friday, November 17, 2023
KVUE, NYSE, SAN, Risk, Person, Phenylephrine, FDA, Hagens Berman, IPO, Life insurance, Pharmaceutical industry

On or around Sept. 12, 2023, the FDA published a briefing document announcing that it was convening an advisory committee to discuss efficacy data available for orally administered phenylephrine as a nasal decongestant.

Key Points: 
  • On or around Sept. 12, 2023, the FDA published a briefing document announcing that it was convening an advisory committee to discuss efficacy data available for orally administered phenylephrine as a nasal decongestant.
  • “We’re focused on investors’ losses and investigating whether Kenvue adequately disclosed commercial risks related to its products containing PE,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.
  • For more information, call Reed Kathrein at 844-916-0895 or email [email protected] .

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Kenvue Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 8, 2023 – (NYSE: KVUE)

Retrieved on: 
Thursday, November 16, 2023
Risk, KVUE, Fraud, NEXT, Prospectus, Phenylephrine, CLASS, Person, Holding company, Security (finance), IPO

DEADLINE: December 8, 2023 Shareholders should not delay in registering for this class action.

Key Points: 
  • DEADLINE: December 8, 2023 Shareholders should not delay in registering for this class action.
  • The deadline to seek to be a lead plaintiff is December 8, 2023.
  • The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.